BSECompany Update28 Sept 2026 · 28 Sept 2026, 05:11 pm

Intimation of Disclosures

Evexia Lifecare Ltd · 524444

✦ AI SummaryRelated Party

Evexia Lifecare Ltd has received disclosure from Shree Saibaba Exim Private Limited, a promoter group entity, regarding the purchase of 25,05,000 equity shares of Evexia Lifecare Limited. The disclosure is made under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment1/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Evexia Lifecare Ltd - 524444 - Disclosure Under Regulation 7(2)(A) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015 And Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011

Attachments (1)

📄

d1d5c1c8-e1e3-44f9-be8c-d710eda6d78c.pdf

pdf

Download →
View document text
eve la EVEXIA LIFECARE LIMITED (Formerly Known as Kavit Industries Ltd.) Date: September 28, 2026 BSE Limited P. ). Towers, Dalal Street, Fort, Mumbai- 400001 Sub: Disclosure under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) Regulations, 2015 Dear Sir/Madam, In accordance with the provisions of Regulation 7(2)(a) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company has received disclosure on September 28, 2026 from M/s. Shree Saibaba Exim Private Limited, Promoter Group with respect to the purchase of 25,05,000 equity shares of Evexia Lifecare Limited. Please find enclosed herewith necessary disclosure under Regulation 7(2)(a) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015. Please take the same on your record. Thanking you. Yours faithfully, (DIN: 01631093) Encl: As Above Reg. Off. : Tundav Anjesar Raod, Vill. Tunday, Tal.: Savli, Vadodara - 391 775 Corporate Office : 9th Floor, Galav Chambers, Sayajigunj, Vadodara-390 020. Ph : +91 265 2361100 / 2200 CIN : L23100GJ1990PLC014692 Email : info@evexialifecare.com Web.: www.evexialifecare.com Shree Saibaba Exim Private Limited 9™ Floor, Galav Chambers, Opp. Sardar Patel Statute, Sayajigunj, Vadodara — 390020 CIN - U51101GJ2013PTC077088 Email ID - sh ibabaexim2022 ail.com Date: September 28, 2026 Managing Director, EVEXIA LIFECARE LIMITED, Vill : Tundao, Tal: Salvi Vadodara- 391775, Gujarat Scrip Code: 524444 Sub: Disclosure under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) Regulations, 2015. Dear Sir/Madam, This is with reference to the purchase of equity shares dated September 28, 2026. This intimation is provided in terms of the provisions of Regulation 7(2)(a) of the SEBI Insider Trading Regulations and all other applicable provisions of Securities and Exchange Board of India Act, 1992 and applicable rules and regulations made thereunder. This letter is intended for the Company’s information and records. Thanking You. Yours Faithfui Name: Shree Saibaba Exj Through Artiben Jayeshbhai Thakkar Director (DIN: 02480296) Encl: As above yunweJ eufa proujo |eobms dowde |;pou)o wetya 3/dnq[ yo/udy ys/dxa yga.aun e ogaJ / oB rwerjya h ju391- sa neusj R 3s0ds )TE( Z8-06- odau 2029 yrwj )ouRunef psposms[ S3IP bmsipou |eobmsipou syexas‘ sdaA yaow eupP % oj syeaJay ojpruS T0 Tz'€€'0 Z8-06- L'LT9 2029 )9'598 2029 ]yasmenov uaep ys3menou 9) E 0 T O W E E A N ] - : A u w i o d 3 4 N I S T s e f Jt 3d juy0n uo o. ay 1 Ed uA u y E : u a _ : w z U ] p U a W S SHesIod gadmu sbmiap gadnIL dosieo ,yAdaoJ pena |fleuse |yAdooJ S3IMJ dpow | sadnuj yAda )40J )gnaoy )40oJ esa/se sqeras‘ djap8a | syexas‘ uis‘ MELe )0UA9J y40IB u;s‘ nqla nou/ |)0ua9J qagau puaos en |qa naas‘ nou/ | gqagauj yRsys QIIs | nias‘ aunpa -draesa | ynSys wauJ‘ sdawA | aunpa rwauq‘ 2( abmuA | zS'0S°0 | ZS0S00 | dnyye | ybmA syera | syera . y5 e NB )4LOYIqIROU lusipa1 L.epiuS( yasnepo nerus dorudeuA: TAHXIV TIADV¥2 TINILEQ me o oysu )eja8 s2IP yeu@‘ ‘DIN/AIN‘ 3eppuasS dpoJ [0OUIBO JUOS gaisou eobmsinou )d.oWw0j a1/wow |LAdaoJ qauoj SAOMJ eup 59 daowoa )4oJ syera yoipru ssond/p |yetas‘ esiSuejo MEIle daisou/ )0UuA9J qiuapoJ s/yur naas‘ sapepae yrSyS yo/oyasJ aunpa s8o( wagys 0a( NYWA: S4129 SEIQRB ]LAe12 ]ruyap dVN‘ YYLIS9800ON glowojaJ gbmA Tz'oB'0 yaayqss‘ yaond syela T'L19 Auqa1 geip ‘defy3nuf‘ sepopeIe E600Z0‘ nn(eeJ WOLLLV6LZ6T9 JWyoa 9207 1oquiaydas :a1eq BIEpOpERA :908[d xo n Z0T§' w:e: nujs 035123( sipa1 y.vpiuB( yabn[vnous nEEeBu daond“-pos31 ISUITOUOP flu&: s235( yniuqaJ )D0UI.R03S 1dn NONOU oJsag )dloyuq flcfiw_.EuE_.u 4nmaa 1512o( )1( .ue d0u uqa HEP pofyuap nupai .abninuou z)1( .0)21.D62/vuA 03184 oYp4.Bas .—.u uofinu:» paraena ssdaJ A)Ad a oJ gnA Nonoue pefna )D0U N093 )1( ,saan1as, yvas uavuiub Aoina .pusvonou axonpaS ]DX25/ qalerjs nepiuS paILAenAas ,]lepju ojdoune93 )ouneP sdapysepous Neru seIqeqB EXIW ,yyroniy yauqdu reAdsyqYB1 LYEPSA J o 0 p a ¥ 2 0 : N Shree Saibaba Exim Private Limited 9 Floor, Galav Chambers, Opp. Sardar Patel Statute, Sayajigunj, Vadodara — 390020 CIN - U51101GJ2013PTC077088 Email ID - shnesaibabuflmzngnil.mm Date: 28/09/2026 To, To, The Department of Corporate Service, The Board of Directors, BSE Limited, EVEXIA LIFECARE LIMITED, Phiroze Jeejeebhoy Tower, Vill: Tundao, Tal: Salvi Vadodara-391775, Dalal Street, Mumbai-400 001. Gujarat Scrip Code: 524444 Dear Sir/Madam, Subject: Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 This is with reference to the disclosure enclosed herewith as required to be made upon purchase of shares of Evexia Lifecare Limited under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Kindly take the above information on record. Thanking you, Yours faithfully, Name: Shree Saibaba Exi Limited Through Artiben Jayeshbhai Thakkar Director (DIN: 02480296) CC To: EVEXIA LIFECARE LIMITED (For information and record) Vill : Tundao, Tal: Salvi Vadodara-391 775, Gujarat Encl: as above Annexure 1 Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) ulations, 2011 Name of the Target Company (TC) EVEXIA LIFECARE LIMITED Name(s) of the acquirer/Seler and Persons Acting in | M/s. Shree Saibaba Exim Private Limited Concert (PAC) with the acquirer/SeHer Whether the acquirer/Seller belongs to | Yes (Promoter Group) Promoter/Promoter group Name(s) of the Stock Exchange(s) where the shares of | BSE Limited TC are Listed Details of the acquisition / dispesal as follows Number % w.r.t. total % w.r.t. share/voting | total diluted capital share/voting wherever capital of applicable(*) | the TC (**) Before the acquisiton / dispesal under consideration, holding of : a) Shares carrying voting rights 12,08,02,716 6.434% 6.434 % b) Shares in the nature of encumbrance (pledge/ lien/ non-disposal undertaking/ others) 0 0.00% 0.00% ¢) Voting rights (VR) otherwise than by shares 0 0.00% 0.00% d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) 0 0.00% 0.00% Total (a+b+c+d) 12,08,02,716 6.434 % 6.434 % Details of acquisition/sale #) Shares carrying voting rights acquired/seld 25,05,000 0.133% 0.133% b) VRs acquired/sold otherwise than by shares 0 0.00% 0.00% ¢) Warrants/convertible securities/any other 0 0.00% 0.00% instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired/sold d) Shares encumbered / invoked/released by the 0 0.00% 0.00% acquirer/seller Total (a+b+ctd) 25,05,000 0.133% 0.133% After the acquisition/sale, holding of: a) Shares carrying voting rights b) Shares encumbered with the acquirer/seller 0 0.00% 0.00% ¢) VRs otherwise than by shares = 0.00% 0.00% d) Warrants/convertible securities/any other 0.00% 0.00% instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after aequisition/sale Total (a+b+ctd) 12,33,07,716 6.568 % 6.568 % Mode of acquisition/sale (e.g. open market / off-market Open Market +—publie—issue——rights—issue /preforential-allotment / inter-se-transeftec.r) Date of acquisition / sale—of-shares/—V-R—or—date—of September 28, 2026 receipt-of-intimation-of allotment-of-shares, whichever is applicable Equity share capital / total voting capital of the TC 187,73,28,995 representing 187,73,28,995 shares before the said acquisition/sale of face value of Re. 1/- each. Equity share capital/ total voting capital of the TC after 187,73,28,995 representing 187,73,28,995 shares the said acquisition/sale of face value of Re. 1/- each. Total diluted share/voting capital of the TC after the 187,73,28,995 representing 187,73,28,995 shares said acquisition/sale of face value of Re. 1/- each. Note: (*)Total share capital/ voting capital to be taken as per the latest filing done by the company to [Showing first 8,000 characters — download PDF for full document]